Davidson Matt
SEC insider (Form 3/4/5 filer). CIK 0001741937. Chief Development Officer at ADIAL PHARMACEUTICALS, INC. (ADIL). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in GLEN ALLEN, VA.
Companies Davidson Matt has filed insider reports for
- ADIAL PHARMACEUTICALS, INC. (ADIL): Director, Officer, Chief Development Officer
Davidson Matt
CIK: 0001741937
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADIL
ADIAL PHARMACEUTICALS, INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 12, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardDirect232.4K shares- - Jun 11, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardDirect61.6K shares- - Jun 11, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardIndirect3.4K shares- - Jun 11, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardDirect1.8K shares- - Jun 11, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardIndirect101 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Award | 232,417 | - | $0 | Direct |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Award | 61,647 | - | $0 | Direct |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Award | 3,427 | - | $0 | Indirect |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Award | 1,822 | - | $0 | Direct |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Award | 101 | - | $0 | Indirect |
1-5 of 5 transactions